300759.SZ WACC - Weighted Average Cost of Capital

The WACC of Pharmaron Beijing Co Ltd (300759.SZ) is 10.7%.

The Cost of Equity of Pharmaron Beijing Co Ltd (300759.SZ) is 11.70%.

The Cost of Debt of Pharmaron Beijing Co Ltd (300759.SZ) is 5.00%.

	Range	Selected
Cost of equity	9.70% - 13.70%	11.70%
Tax rate	14.70% - 16.30%	15.50%
Cost of debt	5.00% - 5.00%	5.00%
WACC	9.0% - 12.4%	10.7%

WACC

300759.SZ WACC calculation

Category	Low	High

Long-term bond rate	2.7%	3.2%
Equity market risk premium	6.1%	7.1%
Adjusted beta	1.15	1.4

Additional risk adjustments	0.0%	0.5%
Cost of equity	9.70%	13.70%

Tax rate	14.70%	16.30%
Debt/Equity ratio	0.15	0.15
Cost of debt	5.00%	5.00%

After-tax WACC	9.0%	12.4%


Selected WACC	10.7%

300759.SZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 300759.SZ:

cost_of_equity (11.70%) = risk_free_rate (2.95%) + equity_risk_premium (6.60%) * adjusted_beta (1.15) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.